缩短抗生素治疗疗程对医院环境中抗菌药物耐药性的影响:模型研究与荟萃分析
该研究构建了3个随机机制模型并荟萃分析5项报告耐药革兰阴性菌定植的随机对照试验,发现缩短疗程可适度减少耐药定植,在高传播环境中效果更明显;但模型提示在抗生素可抑制定植菌的情况下,缩短疗程可能增加特定耐药表型的定植。荟萃分析显示每增加一个抗生素治疗日,耐药定植风险绝对增加7%(80%可信区间3%至11%)。
要点
- 缩短抗生素疗程可适度减少耐药革兰阴性菌定植,高传播环境中效果更明显。
- 荟萃分析显示每增加一个抗生素治疗日,耐药定植风险绝对增加7%(80%可信区间3%至11%)。
- 模型提示当抗生素可抑制定植菌时,缩短疗程可能反常地增加特定耐药表型定植。
核心结论
- 理论和实证证据表明缩短抗生素治疗疗程可减少耐药定植,但机制模型也强调在某些情况下缩短疗程可能反常地增加耐药。
研究设计与样本
- 构建3个随机机制模型,考虑易感和耐药革兰阴性菌的宿主间与宿主内动态。
- 检索MEDLINE和EMBASE从2000年1月1日至2022年10月4日发表的随机对照试验,纳入分配至不同全身抗生素治疗疗程的试验,共识别206项随机试验。
- 其中5项报告耐药革兰阴性菌定植作为结局,纳入荟萃分析,采用逻辑回归,以抗生素治疗时长和从给药到监测培养的时间为自变量。
- 使用Cochrane随机试验偏倚风险工具进行质量评估。
主要发现
- 模型和荟萃分析均提示缩短抗生素治疗疗程可适度减少耐药定植。
- 模型显示缩短疗程在高传播环境比低传播环境更有效减少耐药定植。
- 对接受治疗个体,当耐药菌在抗生素选择压力下快速生长且停药后快速下降时,缩短疗程最有效。
- 在抗生素可抑制定植菌的情况下,缩短抗生素治疗可能增加特定耐药表型的定植。
- 荟萃分析确定单个额外抗生素治疗日与耐药定植风险绝对增加7%相关(80%可信区间3%至11%)。
局限性
- 监测耐药革兰阴性菌定植作为结局的抗生素疗程试验数量少,导致可信区间大,限制了估计值的解释。
- 未来抗生素疗程试验应监测抗生素耐药菌定植作为结局,以更好地为抗生素管理政策提供信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reducing antibiotic treatment duration is a key component of hospital antibiotic stewardship interventions. However, its effectiveness in reducing antimicrobial resistance is uncertain and a clear theoretical rationale for the approach is lacking. In this study, we sought to gain a mechanistic understanding of the relation between antibiotic treatment duration and the prevalence of colonisation with antibiotic-resistant bacteria in hospitalised patients. METHODS AND FINDINGS: We constructed 3 stochastic mechanistic models that considered both between- and within-host dynamics of susceptible and resistant gram-negative bacteria, to identify circumstances under which shortening antibiotic duration would lead to reduced resistance carriage. In addition, we performed a meta-analysis of antibiotic treatment duration trials, which monitored resistant gram-negative bacteria carriage as an outcome. We searched MEDLINE and EMBASE for randomised controlled trials published from 1 January 2000 to 4 October 2022, which allocated participants to varying durations of systemic antibiotic treatments. Quality assessment was performed using the Cochrane risk-of-bias tool for randomised trials. The meta-analysis was performed using logistic regression. Duration of antibiotic treatment and time from administration of antibiotics to surveillance culture were included as independent variables. Both the mathematical modelling and meta-analysis suggested modest reductions in resistance carriage could be achieved by reducing antibiotic treatment duration. The models showed that shortening duration is most effective at reducing resistance carriage in high compared to low transmission settings. For treated individuals, shortening duration is most effective when resistant bacteria grow rapidly under antibiotic selection pressure and decline rapidly when stopping treatment. Importantly, under circumstances whereby administered antibiotics can suppress colonising bacteria, shortening antibiotic treatment may increase the carriage of a particular resistance phenotype. We identified 206 randomised trials, which investigated antibiotic duration. Of these, 5 reported resistant gram-negative bacteria carriage as an outcome and were included in the meta-analysis. The meta-analysis determined that a single additional antibiotic treatment day is associated with a 7% absolute increase in risk of resistance carriage (80% credible interval 3% to 11%). Interpretation of these estimates is limited by the low number of antibiotic duration trials that monitored carriage of resistant gram-negative bacteria, as an outcome, contributing to a large credible interval. CONCLUSIONS: In this study, we found both theoretical and empirical evidence that reducing antibiotic treatment duration can reduce resistance carriage, though the mechanistic models also highlighted circumstances under which reducing treatment duration can, perversely, increase resistance. Future antibiotic duration trials should monitor antibiotic-resistant bacteria colonisation as an outcome to better inform antibiotic stewardship policies.
引用
- Mo Y, Oonsivilai M, Lim C, et al. Implications of reducing antibiotic treatment duration for antimicrobial resistance in hospital settings: A modelling study and meta-analysis. PLoS Med. 2023. PMID: 37319169. doi:10.1371/journal.pmed.1004013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。